hdt-301
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2021 (NCT04844268)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05132907 | Phase 1 | Dec 1, 2021 | C3 Research Associates, HDT Bio, Kaiser Permanente, Rainier Clinical Research Center |
| NCT04844268 | Phase 1 | Oct 31, 2021 | SENAI CIMATEC |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| C3 Research Associates | For profit | 1 | 0 | 1 | 2021 |
| HDT Bio | For profit | 1 | 1 | 1 | 2021 |
| Kaiser Permanente | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Rainier Clinical Research Center | For profit | 1 | 0 | 1 | 2021 |
| SENAI CIMATEC | Academic/Hospital | 1 | 1 | 1 | 2021 |
5 organizations
Page 1 / 1